Stay updated on Semaglutide in Heart Failure & Obesity: Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure & Obesity: Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure & Obesity: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded revision v3.5.0 to the history log and removed revision v3.4.3.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded revision v3.4.3 to the history; v3.4.2 was removed.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the government-funding notice and Revision: v3.4.1 from the history.SummaryDifference0.3%

- Check53 days agoChange DetectedAdded a government funding lapse notice with status guidance and links to cc.nih.gov and opm.gov, and updated the revision from v3.4.0 to v3.4.1 (removing the v3.4.0 entry). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check60 days agoChange DetectedUI updates add a glossary option and color-coded change indicators (green for additions, red for deletions) with display notes; the revision banner shows Revision: v3.4.0 and No FEAR Act data reference was removed (previously Revision: v3.3.4).SummaryDifference0.4%

- Check74 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Semaglutide in Heart Failure & Obesity: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure & Obesity: Clinical Trial page.